Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia.
Saved in:
| Title: | Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Chang YS; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Gills JJ; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Kawabata S; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Onozawa M; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Della Gatta G; Institute for Cancer Genetics and Joint Centers for Systems Biology, Columbia University, New York, NY 10032, USA., Ferrando AA; Institute for Cancer Genetics and Joint Centers for Systems Biology, Columbia University, New York, NY 10032, USA., Aplan PD; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Dennis PA; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. |
| Source: | International journal of oncology [Int J Oncol] 2023 Nov; Vol. 63 (5). Date of Electronic Publication: 2023 Oct 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
